{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:39:42Z","timestamp":1777531182988,"version":"3.51.4"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Ultrasound"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1186\/1476-7120-5-4","type":"journal-article","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T19:11:42Z","timestamp":1169752302000},"source":"Crossref","is-referenced-by-count":35,"title":["Cancer therapy and cardiotoxicity: The need of serial Doppler echocardiography"],"prefix":"10.1186","volume":"5","author":[{"given":"Maurizio","family":"Galderisi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Marra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo Schiano","family":"Lomoriello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moira","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oreste","family":"de Divitiis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,1,25]]},"reference":[{"key":"135_CR1","first-page":"857","volume":"62","author":"JW Mason","year":"1978","unstructured":"Mason JW, Bristow MR, Billingham ME, Daniels JR: Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy. Cancer Treat Rep. 1978, 62: 857-864.","journal-title":"Cancer Treat Rep"},{"key":"135_CR2","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1161\/01.CIR.0000130926.51766.CC","volume":"109","author":"D Cardinale","year":"2004","unstructured":"Cardinale D, Sandri MT, Colombo A, Colombo N, Boeri M, Lamantia G, Civelli M, Peccatori F, Martinelli G, Fiorentini C, Cipolla CM: Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. Circulation. 2004, 109: 2749-2754. 10.1161\/01.CIR.0000130926.51766.CC","journal-title":"Circulation"},{"key":"135_CR3","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1161\/01.CIR.96.8.2641","volume":"96","author":"SE Lipshultz","year":"1997","unstructured":"Lipshultz SE, Rifai N, Sallan SE, Lipsitz SR, Dalton V, Sacks DB, Ottlinger ME: Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation. 1997, 96: 2496-2497.","journal-title":"Circulation"},{"key":"135_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1067\/mhj.2001.113215","volume":"141","author":"AS Maisel","year":"2001","unstructured":"Maisel AS, Koon J, Krishnaswamy P, Kazenegra R, Clopton P, Gardetto N, Morrisey R, Garcia A, Chiu A, De Maria A: Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J. 2001, 141: 367-374. 10.1067\/mhj.2001.113215","journal-title":"Am Heart J"},{"key":"135_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1600-0609.1999.tb01734.x","volume":"62","author":"T Nousiainen","year":"1999","unstructured":"Nousiainen T, Jantunen E, Vanninen E, Remes J, Vuolteenaho O, Hartikainen J: Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma. Eur J Haematol. 1999, 62: 135-141.","journal-title":"Eur J Haematol"},{"key":"135_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer. 1981, 47: 207-214. 10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","journal-title":"Cancer"},{"key":"135_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-4613-2023-4_3","volume-title":"\"Organ Directed Toxicities of Anticancer Drugs\"","author":"C Myers","year":"1988","unstructured":"Myers C: Role of iron in anthracycline action. \"Organ Directed Toxicities of Anticancer Drugs\". Edited by: Hacker M, Lazo J, Tritton T. 1988, 17-30. Boston Mass: Martinus Nijhoff,"},{"key":"135_CR8","first-page":"246","volume-title":"\"Cancer Treatment and the Patient\"","author":"MK Ali","year":"1992","unstructured":"Ali MK: The natural history of anthracycline cardiotoxicity in children. \"Cancer Treatment and the Patient\". Edited by: Muggia F. 1992, 246-255. Baltimore, Md: The John Hopkins University"},{"key":"135_CR9","first-page":"995","volume":"10","author":"AC Braverman","year":"1991","unstructured":"Braverman AC, Antin JH, Plappert MT, Cook EF, Lee RT: Cyclophoshamide cardiotoxicity in bone marrow transplantation.: a prospective evaluation of new dosing regimens. J Clin Oncol. 1991, 10: 995-1000.","journal-title":"J Clin Oncol"},{"key":"135_CR10","first-page":"169","volume":"12","author":"E Dow","year":"1993","unstructured":"Dow E, Schulman H, Agura E: Cyclophosphamide cardiac injury mimicking acute myocardial infarction. Bone Marrow Transplant. 1993, 12: 169-172.","journal-title":"Bone Marrow Transplant"},{"key":"135_CR11","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/archinte.1981.00340060066015","volume":"141","author":"JS Gottdiener","year":"1981","unstructured":"Gottdiener JS, Appelbaum FR, Ferrans VJ, Deisseroth A, Ziegler J: Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med. 1981, 141: 758-763. 10.1001\/archinte.141.6.758","journal-title":"Arch Intern Med"},{"key":"135_CR12","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1200\/JCO.2000.18.8.1725","volume":"18","author":"MT Meinardi","year":"2000","unstructured":"Meinardi MT, Gietema JA, van der Graaf WT, van Veldhuisen DJ, Runne MA, Sluiter WJ, de Vries EG, Willemse PB, Mulder NH, van den Berg MP, Koops HS, Sleijfer DT: Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol. 2000, 18: 1725-1732.","journal-title":"J Clin Oncol"},{"key":"135_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/annonc\/mdf035","volume":"13","author":"N Frickhofen","year":"2002","unstructured":"Frickhofen N, Beck FJ, Jung B, Fuhr HG, Andrasch H, Sigmund M: Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil. Ann Oncol. 2002, 13: 797-801. 10.1093\/annonc\/mdf035","journal-title":"Ann Oncol"},{"key":"135_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0002-9343(01)00808-7","volume":"111","author":"C Lestuzzi","year":"2001","unstructured":"Lestuzzi C, Viei E, Picano E, Meneguzzi N: Coronary vasospasm as a cause of effort-related myocardial ischemia during low dose chronic continuous infusion of 5-fluorouracil. Am J Med. 2001, 111: 316-318. 10.1016\/S0002-9343(01)00808-7","journal-title":"Am J Med"},{"key":"135_CR15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0140-6736(94)91602-0","volume":"343","author":"P Sevelda","year":"1994","unstructured":"Sevelda P, Mayerhofer K, Obermair A, Stolzlechner J, Kurz C: Thrombosis with paclitaxel. Lancet. 1994, 343: 727-731. 10.1016\/S0140-6736(94)91602-0","journal-title":"Lancet"},{"key":"135_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<797::AID-CNCR25>3.0.CO;2-M","volume":"83","author":"US Kammula","year":"1998","unstructured":"Kammula US, White DE, Rosenberg SA: Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer. Cancer. 1998, 83: 797-805. 10.1002\/(SICI)1097-0142(19980815)83:4<797::AID-CNCR25>3.0.CO;2-M","journal-title":"Cancer"},{"key":"135_CR17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.7326\/0003-4819-117-4-292","volume":"117","author":"SR Frankel","year":"1992","unstructured":"Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell RP: The \"retinoic acid syndrome\" in acute promyelocitic leukemia. Ann Intern Med. 1992, 117: 292-296.","journal-title":"Ann Intern Med"},{"key":"135_CR18","first-page":"90","volume":"95","author":"MS Tallman","year":"2000","unstructured":"Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Rowe JM, Francois C, Larson RS, Wiernik PH: Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood. 2000, 95: 90-95.","journal-title":"Blood"},{"key":"135_CR19","doi-asserted-by":"crossref","unstructured":"Soignet SL: Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia. Oncologist. 2001, 11-16. 10.1634\/theoncologist.6-suppl_2-11. Suppl 2","DOI":"10.1634\/theoncologist.6-suppl_2-11"},{"key":"135_CR20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1056\/NEJMoa011573","volume":"346","author":"H Kantarjian","year":"2002","unstructured":"Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C, Niederwieser D, Resta D, Capdeville R, Zoellner U, Talpaz M, Druker B, Goldman J, O'Brien SG, Russell N, Fischer T, Ottmann O, Cony-Makhoul P, Facon T, Stone R, Miller C, Tallman M, Brown R, Schuster M, Loughran T, Gratwohl A, Mandelli F, Saglio G, Lazzarino M, Russo D, Baccarani M, Morra E, : Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med. 2002, 346: 645-652. 10.1056\/NEJMoa011573","journal-title":"N Engl J Med"},{"key":"135_CR21","first-page":"489","volume":"61","author":"MH Cohen","year":"1977","unstructured":"Cohen MH, Broder LE, Fossieck BE, Ihde DC, Minna JD: Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma. Cancer Treat Rep. 1977, 61: 489-490.","journal-title":"Cancer Treat Rep"},{"key":"135_CR22","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/ajhp\/60.16.1631","volume":"60","author":"RJ Cersosimo","year":"2003","unstructured":"Cersosimo RJ: Monoclonal antibodies in the treatment of cancer, part 2. Am J Health Syst Pharm. 2003, 60: 1631-1641.","journal-title":"Am J Health Syst Pharm"},{"key":"135_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1200\/JCO.2004.01.120","volume":"22","author":"EA Perez","year":"2004","unstructured":"Perez EA, Rodeheffer R: Clinical cardiac tolerability of trastuzumab. J Clin Oncol. 2004, 22: 322-329. 10.1200\/JCO.2004.01.120","journal-title":"J Clin Oncol"},{"key":"135_CR24","unstructured":"Walter J, Miller H, Bomford CK, Kunkler IH, Walter , Millers , : Textbook of radiotherapy, radiation physics, therapy and oncology. 2002, Edinburgh: Churchill Livingstone"},{"key":"135_CR25","first-page":"244","volume":"27","author":"D Keefe","year":"2000","unstructured":"Keefe D: Cardiovascular emergencies in the cancer patient. Semin Oncol. 2000, 27: 244-55.","journal-title":"Semin Oncol"},{"key":"135_CR26","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/hrt.69.6.496","volume":"69","author":"F Orzan","year":"1993","unstructured":"Orzan F, Brusca A, Conte MR, Presbitero P, Figliomeni MC: Severe coronary artery disease after radiation therapy of the chest and mediastinum: clinical presentation and treatment. Br Heart J. 1993, 69: 496-500.","journal-title":"Br Heart J"},{"key":"135_CR27","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0046-8177(96)90447-5","volume":"27","author":"JP Veinot","year":"1996","unstructured":"Veinot JP, Edwards WD: Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol. 1996, 27: 766-773. 10.1016\/S0046-8177(96)90447-5","journal-title":"Hum Pathol"},{"key":"135_CR28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1200\/JCO.1985.3.4.546","volume":"3","author":"DJ Perrault","year":"1985","unstructured":"Perrault DJ, Levy M, Herman JD, Burns RJ, Bar Shlomo BZ, Druck MN, Wu WQ, McLaughlin PR, Gilbert BW: Echocardiographic abnormalities following cardiac radiation. J Clin Oncol. 1985, 3: 546-551.","journal-title":"J Clin Oncol"},{"key":"135_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/1097-0142(19870701)60:1<31::AID-CNCR2820600107>3.0.CO;2-D","volume":"60","author":"S Pohjola-Sintonen","year":"1987","unstructured":"Pohjola-Sintonen S, Totterman KJ, Salmo M, Siltanen P: Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease. Cancer. 1987, 60: 31-37. 10.1002\/1097-0142(19870701)60:1<31::AID-CNCR2820600107>3.0.CO;2-D","journal-title":"Cancer"},{"key":"135_CR30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/10428190310001593607","volume":"45","author":"A Zsary","year":"2004","unstructured":"Zsary A, Szucs S, Keltai K, Schneider T, Rosta A, Sarman P, Fenyvesi T, Karadi I: Endothelins: a possible mechanism of cytostatics-induced cardiomyopathy. Leuk Lymphoma. 2004, 45: 351-355. 10.1080\/10428190310001593607","journal-title":"Leuk Lymphoma"},{"key":"135_CR31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1159\/000238798","volume":"36","author":"I Low-Friederich","year":"1990","unstructured":"Low-Friederich I, von Bredow F, Schoeppe W: In vitro studies on the chemotherapeutics. Chemotherapy. 1990, 36: 416-421.","journal-title":"Chemotherapy"},{"key":"135_CR32","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/00019501-199310000-00014","volume":"4","author":"R Voisard","year":"1993","unstructured":"Voisard R, Dar4tsch PC, Seitzer U, Hannekum A, Roth D, Kochs M, Hombach V: The in-vitro effect of antineoplastic agents on proliferative activity and cytoskeletal components of plaque-derived smooth-muscle cells from human coronary arteries. Coronary Artery Dis. 1993, 4: 935-942.","journal-title":"Coronary Artery Dis"},{"key":"135_CR33","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jvs.2003.12.021","volume":"39","author":"J Heckenkamp","year":"2004","unstructured":"Heckenkamp J, Nigri GR, Waterman PR, Overhaus M, Kossodo SC, Lamuraglia GM: Gamma-irradiation modulates vascular smooth muscle cell and extracellular matrix function: Implications for neointimal development. J Vasc Surg. 2004, 39: 1097-1103. 10.1016\/j.jvs.2003.12.021","journal-title":"J Vasc Surg"},{"key":"135_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7326\/0003-4819-125-1-199607010-00008","volume":"125","author":"K Shan","year":"1996","unstructured":"Shan K, Lincoff AM, Young JB: Anthracycline-induced cardiotoxicity. Ann Intern Med. 1996, 125: 47-58.","journal-title":"Ann Intern Med"},{"key":"135_CR35","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2459\/01.JCM.0000237914.12915.dd","volume":"7","author":"E Hrovatin","year":"2006","unstructured":"Hrovatin E, Viel E, Lestuzzi C, Tartuferi L, Zardo F, Brieda M, Dametto E, Piazza R, Antonini-Canterin F, Vaccher E, Meneguzzo N, Nicolosi GL: Severe ventricular dysrhythmias and silent ischemia during infusion of the antimetabolite 5-fluorouracil and cis-platin. J Cardiovasc Med. 2006, 7: 637-640.","journal-title":"J Cardiovasc Med"},{"key":"135_CR36","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2165\/00003495-199957040-00003","volume":"57","author":"K Becker","year":"1999","unstructured":"Becker K, Erckenbrecht JF, Haussinger D, Frieling T: Cardiotoxicity of the antiproliferative compound fluorouracil. Drugs. 1999, 57: 475-484. 10.2165\/00003495-199957040-00003","journal-title":"Drugs"},{"key":"135_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000174999","volume":"80","author":"D Schechter","year":"1992","unstructured":"Schechter D, Nagler A, Ackerstein A, Nassar H, Admon D, Naparstek E, Rein AJ: Recombinant interleukin-2 and interferon alpha immunotherapy following autologous bone marrow transplantation. Cardiology. 1992, 80: 168-171.","journal-title":"Cardiology"},{"key":"135_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2459\/01.JCM.0000199785.94760.50","volume":"7","author":"A Sestito","year":"2006","unstructured":"Sestito A, Sgueglia GA, Pozzo C, Cassano A, Barone C, Crea F, Lanza GA: Coronary artery spasm induced by capecitabine. J Cardiovascv Med. 2006, 7: 136-138.","journal-title":"J Cardiovascv Med"},{"key":"135_CR39","doi-asserted-by":"publisher","first-page":"881","DOI":"10.7326\/0003-4819-133-11-200012050-00012","volume":"133","author":"K Ohnishi","year":"2001","unstructured":"Ohnishi K, Yoshida H, Shigeno K, Nakamura S, Fujisawa S, Naito K, Shinjo K, Fujita Y, Matsui H, Takeshita A, Sugiyama S, Satoh H, Terada H, Ohno R: Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med. 2001, 133: 881-885.","journal-title":"Ann Intern Med"},{"key":"135_CR40","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0140-6736(00)02051-1","volume":"355","author":"H Nakamae","year":"2000","unstructured":"Nakamae H, Tsumura K, Hino M, Hayashi T, Tatsumi N: QT dispersion as a predictor of acute heart failure after high-dose cyclophosphamide. Lancet. 2000, 355: 805-806. 10.1016\/S0140-6736(00)02051-1","journal-title":"Lancet"},{"key":"135_CR41","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/08880010290097387","volume":"19","author":"M Gupta","year":"2002","unstructured":"Gupta M, Thaler HT, Steinherz L: Presence of prolonged dispersion of qt intervals in late survivors of childhood anthracycline therapy. Pediatr Hematol Oncol. 2002, 19: 533-542. 10.1080\/08880010290097387","journal-title":"Pediatr Hematol Oncol"},{"key":"135_CR42","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1200\/JCO.2005.05.827","volume":"23","author":"MS Ewer","year":"2005","unstructured":"Ewer MS, Lippman SM: Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity. J Clin Oncol. 2005, 23: 2900-2902. 10.1200\/JCO.2005.05.827","journal-title":"J Clin Oncol"},{"key":"135_CR43","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/NEJMoa032566","volume":"350","author":"MR Zile","year":"2004","unstructured":"Zile MR, Baicu CF, Gaasch WH: Diastolic heart failure: abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med. 2004, 350: 1953-1959. 10.1056\/NEJMoa032566","journal-title":"N Engl J Med"},{"key":"135_CR44","first-page":"2325","volume":"43","author":"J Krupicka","year":"2002","unstructured":"Krupicka J, Markova J, Pohlreich D, Kozak T, Linkova H, Diehl V: Echocardiographic evaluation of acute cardiotoxicity in the treatment of Hodgkin disease according to the German Hodgkin's Lymphoma Study Group. Leuk Lymphoma. 2002, 43: 2325-2329.","journal-title":"Leuk Lymphoma"},{"key":"135_CR45","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/0002-8703(89)90077-X","volume":"118","author":"B Marchandise","year":"1989","unstructured":"Marchandise B, Schroeder E, Bosly A, Doyen C, Weynants P, Kremer R, Pouleur H: Early detection of doxorubicin cardiotoxicity: interest of Doppler echocardiographic analysis of left ventricular filling dynamics. Am Heart J. 1989, 118: 92-98. 10.1016\/0002-8703(89)90077-X","journal-title":"Am Heart J"},{"key":"135_CR46","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/hrt.81.4.419","volume":"81","author":"G Tjeerdsma","year":"1999","unstructured":"Tjeerdsma G, Meinardi MT, van Der Graaf WT, van Den Berg MP, Mulder NH, Crijns HJ, de Vries EG, van Veldhuisen DJ: Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables. Heart. 1999, 81: 419-423.","journal-title":"Heart"},{"key":"135_CR47","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3109\/02841869409121776","volume":"33","author":"MS Ewer","year":"1994","unstructured":"Ewer MS, Ali MK, Gibbs HR, Swafford J, Graff KL, Cangir A, Jaffe N, Thapar MK: Cardiac diastolic function in pediatric patients receiving doxorubicin. Acta Oncol. 1994, 33: 645-649.","journal-title":"Acta Oncol"},{"key":"135_CR48","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/clc.4960241006","volume":"24","author":"D Iarussi","year":"2001","unstructured":"Iarussi D, Galderisi M, Ratti G, Tedesco MA, Indolfi P, Casale F, Di Tullio MT, de Divitiis O, Iacono A: Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood. Clin Cardiol. 2001, 24: 663-669.","journal-title":"Clin Cardiol"},{"key":"135_CR49","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/PL00021001","volume":"23","author":"B Ocal","year":"2002","unstructured":"Ocal B, Oguz D, Karademir S, Birgen D, Yuksek N, ertem U, Cabuk F: Myocardial performance index combining systolic and diastolic myocardial performance in doxorubicin-treated patients and its correlation to conventional echo\/Doppler indices. Pediatr Cardiol. 2002, 23: 522-527.","journal-title":"Pediatr Cardiol"},{"key":"135_CR50","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1002\/cncr.11274","volume":"97","author":"K Sorensen","year":"2003","unstructured":"Sorensen K, Levitt GA, Bull C, Dorup I, Sullivan ID: Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study. Cancer. 2003, 97: 1991-1998. 10.1002\/cncr.11274","journal-title":"Cancer"},{"key":"135_CR51","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/sj.bmt.1703132","volume":"28","author":"P Morandi","year":"2001","unstructured":"Morandi P, Ruffini PA, Benvenuto GM, La Vecchia L, Mezzena G, Raimondi R: Serum cardiac troponin I levels and ECG\/Echo monitoring in breast cancer patients undergoing high-dose (7 g\/m(2)) cyclophosphamide. Bone Marrow Transplant. 2001, 28: 277-282. 10.1038\/sj.bmt.1703132","journal-title":"Bone Marrow Transplant"},{"key":"135_CR52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/sj.bjc.6601883","volume":"91","author":"E Baldini","year":"2004","unstructured":"Baldini E, Prochilo T, Salvadori B, Bolognesi A, Aldrighetti D, Venturini M, Rosso R, Carnino F, Gallo L, Giannessi P, Conte PF, Orlandini C, Bruzzi P: Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safety. Br J Cancer. 2004, 91: 45-49. 10.1038\/sj.bjc.6601883","journal-title":"Br J Cancer"},{"key":"135_CR53","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1002\/1097-0142(19941115)74:10<2850::AID-CNCR2820741018>3.0.CO;2-T","volume":"74","author":"WH Kruit","year":"1994","unstructured":"Kruit WH, Punt KJ, Goey SH, de Mulder PH, van Hoogenhuyze DC, Henzen-Logmans SC, Stoter G: Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complication. Cancer. 1994, 74: 2850-2856. 10.1002\/1097-0142(19941115)74:10<2850::AID-CNCR2820741018>3.0.CO;2-T","journal-title":"Cancer"},{"key":"135_CR54","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1046\/j.1365-2141.2003.04288.x","volume":"121","author":"SK Sohn","year":"2003","unstructured":"Sohn SK, Kim JG, Kim DH, Lee KB: Cardiac morbidity in advanced chronic myelogenous leukaemia patients treated by successive allogenic stem cell transplantation with busulphan\/cyclophosphamide conditioning after imatinib mesylate administration. Br J Hematol. 2003, 121: 469-472. 10.1046\/j.1365-2141.2003.04288.x. 10.1046\/j.1365-2141.2003.04288.x","journal-title":"Br J Hematol"},{"key":"135_CR55","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1080\/10428190400002293","volume":"45","author":"B Rotoli","year":"2004","unstructured":"Rotoli B, Catalano L, Galderisi M, Luciano L, Pollio G, Guerriero A, D'Errico A, Mecucci C, La Starza R, Frigeri F, Di Francia R, Pinto A: Rapid reversion of Loeffler's endocarditis by imatinib in early stage clonal hypereosinophilic syndrome. Leuk Limphoma. 2004, 45: 2503-2507. 10.1080\/10428190400002293. 10.1080\/10428190400002293","journal-title":"Leuk Limphoma"},{"key":"135_CR56","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1200\/JCO.1985.3.4.546","volume":"3","author":"DJ Perrault","year":"1985","unstructured":"Perrault DJ, Levy M, Herman JD, Burns RJ, Bar Shlomo BZ, Druck MN, Wu WQ, McLaughlin PR, Gilbert BW: Echocardiographic abnormalities following cardiac radiation. J Clin Oncol. 1985, 3: 546-551.","journal-title":"J Clin Oncol"},{"key":"135_CR57","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.ahj.2004.12.026","volume":"150","author":"PA Heidenreich","year":"2005","unstructured":"Heidenreich PA, Hancock SL, Vagelos RH, Lee BK, Schnittger I: Diastolic dysfunction after mediastinal irradiation. Am Heart J. 2005, 150: 977-982. 10.1016\/j.ahj.2004.12.026","journal-title":"Am Heart J"},{"key":"135_CR58","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0735-1097(03)00759-9","volume":"42","author":"PA Heidenreich","year":"2003","unstructured":"Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I: Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol. 2003, 42: 750-751. 10.1016\/S0735-1097(03)00759-9","journal-title":"J Am Coll Cardiol"},{"key":"135_CR59","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1136\/heart.85.4.430","volume":"85","author":"J Allen","year":"2001","unstructured":"Allen J, Thomson JD, Lewis IJ, Gibbs JL: Mitral regurgitation after anthracycline treatment for childhood malignancy. Heart. 2001, 85: 430-432. 10.1136\/heart.85.4.430","journal-title":"Heart"},{"key":"135_CR60","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1136\/hrt.75.6.591","volume":"75","author":"MB Lund","year":"1996","unstructured":"Lund MB, Ihlen H, Voss BM, Abrahamsen AF, Nome O, Kongerud J, Stugaard M, Forfang K: Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study. Heart. 1996, 75: 591-596.","journal-title":"Heart"},{"key":"135_CR61","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1001\/jama.290.21.2831","volume":"290","author":"MC Hull","year":"2003","unstructured":"Hull MC, Morris CG, Pepine CJ, Mendenhall NP: Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA. 2003, 290: 2831-2837. 10.1001\/jama.290.21.2831","journal-title":"JAMA"},{"key":"135_CR62","doi-asserted-by":"publisher","first-page":"7475","DOI":"10.1200\/JCO.2005.13.755","volume":"23","author":"DA Patt","year":"2005","unstructured":"Patt DA, Goodwin JS, Kuo YF, Freeman JL, Zhang DD, Buchholz TA, Hortobagyi GN, Giordano SH: Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol. 2005, 23: 7475-7482. 10.1200\/JCO.2005.13.755","journal-title":"J Clin Oncol"},{"key":"135_CR63","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0002-9149(03)00546-0","volume":"92","author":"D Hering","year":"2003","unstructured":"Hering D, Faber L, Horstkotte D: Echocardiographic features of radiation-associated valvular disease. Am J Cardiol. 2003, 92: 226-230. 10.1016\/S0002-9149(03)00546-0","journal-title":"Am J Cardiol"},{"key":"135_CR64","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/00132580-200211000-00008","volume":"4","author":"AS Retter","year":"2002","unstructured":"Retter AS: Pericardial.disease in the oncology patient. Heart Dis. 2002, 4: 387-391. 10.1097\/00132580-200211000-00008","journal-title":"Heart Dis"},{"key":"135_CR65","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1023\/A:1011196910325","volume":"12","author":"H Dazzi","year":"2001","unstructured":"Dazzi H, Kaufmann K, Follath F: Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia. Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity in patients treated for acute leukaemia at the University Hospital of Zurich, Switzerland, between 1990 and 1996. Ann Oncol. 2001, 12: 963-966. 10.1023\/A:1011196910325","journal-title":"Ann Oncol"},{"key":"135_CR66","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.clon.2004.09.016","volume":"17","author":"AM Gaya","year":"2005","unstructured":"Gaya AM, Ashford RF: Cardiac complications of radiation therapy. Clin Oncol. 2005, 17: 153-159. 10.1016\/j.clon.2004.09.016. 10.1016\/j.clon.2004.09.016","journal-title":"Clin Oncol"},{"key":"135_CR67","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0735-1097(03)00760-5","volume":"42","author":"BF Byrd 3rd","year":"2003","unstructured":"Byrd BF, Mendes LA: Cardiac complications of mediastinal radiotherapy. The other side of the coin. J Am Coll Cardiol. 2003, 42: 750-751. 10.1016\/S0735-1097(03)00760-5","journal-title":"J Am Coll Cardiol"},{"key":"135_CR68","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1148\/89.2.302","volume":"89","author":"JR Stewart","year":"1967","unstructured":"Stewart JR, Cohn KE, Fajardo LF, Hancock EW, Kaplan HS: Radiation induced heart disease: a study of twenty-five patients. Radiology. 1967, 89: 302-310.","journal-title":"Radiology"},{"key":"135_CR69","doi-asserted-by":"publisher","first-page":"338","DOI":"10.7326\/0003-4819-94-3-338","volume":"94","author":"MM Applefeld","year":"1981","unstructured":"Applefeld MM, Cole JF, Pollock SH, Sutton FJ, Slawson RG, Singleton RT, Wiernik PH: The late appearance of chronic pericardial disease in patients treated by radiotherapy for Hodgkin's disease. Ann Intern Med. 1981, 94: 338-341.","journal-title":"Ann Intern Med"},{"key":"135_CR70","doi-asserted-by":"publisher","first-page":"435","DOI":"10.7326\/0003-4819-124-5-199603010-00019","volume":"124","author":"GC Kane","year":"1996","unstructured":"Kane GC, Edie RN, Mannion JD: Delayed appearance of effusive-constrictive pericarditis after radiation for Hodgkin lymphoma. Ann Intern Med. 1996, 124: 435-436.","journal-title":"Ann Intern Med"},{"key":"135_CR71","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2459\/01.JCM.0000234772.73454.57","volume":"7","author":"M Pepi","year":"2006","unstructured":"Pepi M, Muratori M: Echocardiography in the diagnosis and management of pericardial disease. J Cardiovasc Med. 2006, 7: 533-544.","journal-title":"J Cardiovasc Med"},{"key":"135_CR72","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1161\/01.CIR.50.2.239","volume":"50","author":"M Hortowitz","year":"1974","unstructured":"Hortowitz M, Scultz C, Stinson E: Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation. 1974, 50: 239-247.","journal-title":"Circulation"},{"key":"135_CR73","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1148\/radiology.213.1.r99oc07167","volume":"213","author":"LJ King","year":"1999","unstructured":"King LJ, Hasnain SN, Webb JA, Kingston JE, Shafford EA, Lister TA, Shamash J, Reznek RH: Asymptomatic carotid arterial disease in young patients following neck radiation therapy for Hodgkin lymphoma. Radiology. 1999, 213: 167-172.","journal-title":"Radiology"},{"key":"135_CR74","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/cncr.21636","volume":"106","author":"DA Patel","year":"2006","unstructured":"Patel DA, Kochanski J, Suen AW, Fajardo LF, Hancock SL, Knox SJ: Clinical manifestations of non coronary atherosclerotic vascular disease after moderate dose irradiation. Cancer. 2006, 106: 718-725. 10.1002\/cncr.21636","journal-title":"Cancer"},{"key":"135_CR75","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.1200\/JCO.2005.15.107","volume":"23","author":"DC Bowers","year":"2005","unstructured":"Bowers DC, McNeil DE, Liu Y, Yasui Y, Stovall M, Gurney JG, Hudson MM, Donaldson SS, Packer RJ, Mitby PA, Kasper CE, Robison LL, Oeffinger KC: Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2005, 23: 6508-6515. 10.1200\/JCO.2005.15.107","journal-title":"J Clin Oncol"},{"key":"135_CR76","unstructured":"Marra F, Galderisi M, Camera A, Rinaldi CR, Innelli P, Rotoli B, de Divitiis O: Doppler echocardiography during follow-up ofthe hematological patients undergoing chemotherapy. Int J Cardiol."},{"key":"135_CR77","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S1525-2167(03)00017-9","volume":"4","author":"M Bountioukos","year":"2003","unstructured":"Bountioukos M, Doorduijn JK, Roelandt JR, Vourvouri EC, Bax JJ, Schinkel AF, Kertai MD, Sonneveld P, Poldermans D: Repetitive dobutamine stress echocardiography for the prediction of anthracycline cardiotoxicity. Eur J Echocardiogr. 2003, 4: 300-305. 10.1016\/S1525-2167(03)00017-9","journal-title":"Eur J Echocardiogr"},{"key":"135_CR78","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1053\/euje.2000.0037","volume":"1","author":"Y Cottin","year":"2000","unstructured":"Cottin Y, L'huillier I, Casasnovas O, Geoffroy C, Caillot D, Zeller M, Solary E, Guy H, Wolf JE: Dobutamine stress echocardiography identifies anthracycline cardiotoxicity. Eur J Echocardiogr. 2000, 1: 180-183. 10.1053\/euje.2000.0037","journal-title":"Eur J Echocardiogr"},{"key":"135_CR79","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1067\/mhj.2000.108237","volume":"140","author":"L Lanzarini","year":"2000","unstructured":"Lanzarini L, Bossi G, Laudisa ML, Klersy C, Arico M: Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines. Am Heart J. 2000, 140: 315-323. 10.1067\/mhj.2000.108237","journal-title":"Am Heart J"},{"key":"135_CR80","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/0735-1097(92)90497-B","volume":"19","author":"SE Klewer","year":"1992","unstructured":"Klewer SE, Goldberg SJ, Donnerstein RL, Berg RA, Hutter JJ: Dobutamine stress echocardiography: a sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer. J Am Coll Cardiol. 1992, 19: 394-401.","journal-title":"J Am Coll Cardiol"},{"key":"135_CR81","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1442-200X.2006.02210.x","volume":"48","author":"H Hamada","year":"2006","unstructured":"Hamada H, Ohkubo T, Maeda M, Ogawa S: Evaluation of cardiac reserved function by high-dose dobutamine-stress echocardiography in asymptomatic anthracycline-treated survivors of childhood cancer. Pediatr Int. 2006, 48: 313-320. 10.1111\/j.1442-200X.2006.02210.x","journal-title":"Pediatr Int"},{"key":"135_CR82","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1161\/01.CIR.69.4.775","volume":"69","author":"RM Hoyt","year":"1984","unstructured":"Hoyt RM, Skorton DJ, Collins SM, Melton HE: Ultrasonic backscatter and collagen in normal ventricular myocardium. Circulation. 1984, 69: 775-782.","journal-title":"Circulation"},{"key":"135_CR83","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1161\/01.CIR.81.1.58","volume":"81","author":"E Picano","year":"1990","unstructured":"Picano E, Pelosi G, Marzilli M, Lattanzi F, Benassi A, Landini L, L'Abbate A: In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans. Circulation. 1990, 81: 58-64.","journal-title":"Circulation"},{"key":"135_CR84","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/0735-1097(95)00026-Z","volume":"25","author":"V Di Bello","year":"1995","unstructured":"Di Bello V, Talarico L, Picano E, Di Muro C, Landini L, Paterni M, Matteucci E, Giusti C, Giampietro O: Increased echodensity of myocardial wall in the diabetic heart: an ultrasound tissue characterization study. J Am Coll Cardiol. 1995, 25: 1408-1415. 10.1016\/0735-1097(95)00026-Z","journal-title":"J Am Coll Cardiol"},{"key":"135_CR85","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000077884","volume":"50","author":"S Barutca","year":"2004","unstructured":"Barutca S, Ceyhan C, Meydan N, Ozturk B, Tekten T, Onbasili A, Kadikoylu G, Bolaman Z: A new perspective on cardiotoxicity of 5-fluorouracil. A novel research tool 'cardiac ultrasonic integrated backscatter analysis' indicates transient, subclinical myocardial dysfunction due to high-dose leucovorin and infusional 5-fluorouracil regimen. Chemotherapy. 2004, 50: 113-118. 10.1159\/000077884","journal-title":"Chemotherapy"},{"key":"135_CR86","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S0894-7317(05)80007-0","volume":"8","author":"A Lange","year":"1995","unstructured":"Lange A, Moran CM, Palka P, Fenn LN, Sutherland GR, McDicken WN: The variation of integrated backscatter in human hearts in differing ultrasonic transthoracic views. J Am Soc Echocardiogr. 1995, 8: 830-838. 10.1016\/S0894-7317(05)80007-0","journal-title":"J Am Soc Echocardiogr"},{"key":"135_CR87","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1067\/S0894-7317(03)00425-5","volume":"16","author":"H Nagai","year":"2003","unstructured":"Nagai H, Omi W, Yuasa T, Sakagami S, Takata S, Kobayashi K: Ultrasonic analysis of anthracycline-induced myocardial damage using cyclic variation of integrated backscatter. J Am Soc Echocardiogr. 2003, 16: 808-813. 10.1067\/S0894-7317(03)00425-5","journal-title":"J Am Soc Echocardiogr"},{"key":"135_CR88","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S0735-1097(00)00800-7","volume":"36","author":"K Isaaz","year":"2000","unstructured":"Isaaz K: What are we actually measuring by Doppler tissue imaging?. J Am Coll Cardiol. 2000, 36: 897-899. 10.1016\/S0735-1097(00)00800-7","journal-title":"J Am Coll Cardiol"},{"key":"135_CR89","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S0735-1097(02)02921-2","volume":"41","author":"M Wang","year":"2003","unstructured":"Wang M, Yip GW, Wang AY, Zhang Y, Ho PY, Tse MK, Lam PK, Sanderson JE: Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol. 2003, 41: 820-826. 10.1016\/S0735-1097(02)02921-2","journal-title":"J Am Coll Cardiol"},{"key":"135_CR90","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1161\/01.CIR.102.15.1788","volume":"102","author":"SR Ommen","year":"2000","unstructured":"Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ: Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation. 2000, 102: 1788-1794.","journal-title":"Circulation"},{"key":"135_CR91","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.euje.2005.04.009","volume":"7","author":"S Tassan-Mangina","year":"2006","unstructured":"Tassan-Mangina S, Codorean D, Metivier M, Costa B, Himberlin C, Jouannaud C, Blaise AM, Elaerts J, Nazeyrollas P: Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study. Eur J Echocardiogr. 2006, 7: 141-146. 10.1016\/j.euje.2005.04.009","journal-title":"Eur J Echocardiogr"},{"key":"135_CR92","first-page":"263","volume":"95","author":"S Tassan-Mangina","year":"2002","unstructured":"Tassan-Mangina S, Brasselet C, Nazeyrollas P, Collot-Bigot M, Costa B, Blaise AM, Laury P, Bonfils L, Metz D, Elaerts J: Value of pulsed Doppler tissue imaging for early detection of myocardial dysfunction with anthracyclines. Arch Mal Coeur Vaiss. 2002, 95: 263-268.","journal-title":"Arch Mal Coeur Vaiss"},{"key":"135_CR93","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0301-5629(00)00252-0","volume":"26","author":"L Kapusta","year":"2000","unstructured":"Kapusta L, Thijssen JM, Groot-Loonen J, Antonius T, Mulder J, Daniels O: Tissue Doppler imaging in detection of myocardial dysfunction in survivors of childhood cancer treated with anthracyclines. Ultrasound Med Biol. 2000, 26: 1099-1108. 10.1016\/S0301-5629(00)00252-0","journal-title":"Ultrasound Med Biol"},{"key":"135_CR94","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1164\/ajrccm.156.5.96-07096","volume":"156","author":"D Lichtenstein","year":"1997","unstructured":"Lichtenstein D, Meziere G, Biderman P, Gepner A, Barre O: The comet-tail artifact. An ultrasound sign of alveolar-interstitial syndrome. Am J Respir Crit Care Med. 1997, 156: 1640-1646.","journal-title":"Am J Respir Crit Care Med"},{"key":"135_CR95","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s001340050771","volume":"24","author":"D Lichtenstein","year":"1998","unstructured":"Lichtenstein D, Meziere G: A lung ultrasound sign allowing bedside distinction between pulmonary edema and COPD: the comet-tail artifact. Intensive Care Med. 1998, 24: 1331-1334. 10.1007\/s001340050771","journal-title":"Intensive Care Med"},{"key":"135_CR96","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.echo.2005.05.019","volume":"19","author":"E Picano","year":"2006","unstructured":"Picano E, Frassi F, Agricola E, Gligorova S, Gargani L, Mottola G: Ultrasound lung comets: a clinically useful sign of extravascular lung water. J Am Soc Echocardiogr. 2006, 19: 356-363. 10.1016\/j.echo.2005.05.019","journal-title":"J Am Soc Echocardiogr"},{"key":"135_CR97","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1373\/clinchem.2005.050153","volume":"51","author":"MT Sandri","year":"2005","unstructured":"Sandri MT, Salvatici M, Cardinale D, Zorzino L, Passerini R, Lentati P, Leon M, Civelli M, Martinelli G, Cipolla CM: N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: a marker predictive of cardiac dysfunction?. Clin Chem. 2005, 51: 1405-1410. 10.1373\/clinchem.2005.050153","journal-title":"Clin Chem"},{"key":"135_CR98","doi-asserted-by":"crossref","unstructured":"Camus B, Kudoh S, Ebina M: Interstitial lung disease associated with drug therapy. Cancer. 2004, S18-S23. Suppl 2","DOI":"10.1038\/sj.bjc.6602063"},{"key":"135_CR99","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1053\/crad.2000.0542","volume":"55","author":"GC Ooi","year":"2000","unstructured":"Ooi GC, Kwong DL, Chan KN, Ngan H, Lock DT, Lam WK, Chan FL, Au G, Tsang KW: Serial HRCT lung change after 3-field radiation treatment of breast cancer. Clin Radiol. 2000, 55: 817-824. 10.1053\/crad.2000.0542","journal-title":"Clin Radiol"}],"container-title":["Cardiovascular Ultrasound"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1476-7120-5-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-7120-5-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-7120-5-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-7120-5-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:15:42Z","timestamp":1556064942000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiovascularultrasound.biomedcentral.com\/articles\/10.1186\/1476-7120-5-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["135"],"URL":"https:\/\/doi.org\/10.1186\/1476-7120-5-4","relation":{},"ISSN":["1476-7120"],"issn-type":[{"value":"1476-7120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]},"article-number":"4"}}